Skip to content

Clinical trials

Phase 1/2 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 1/2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20091
20111
20132
20142
20152
20162
20191
20201
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lexeo Therapeutics2
Mayo Clinic2
Abramson Cancer Center at Penn Medicine1
Atrium Therapeutics1
Celladon Corporation1
CoRepair, Inc.1
Craig McDonald, MD1
Horng Chen1
Hospital General Universitario Gregorio Marañon1
Hospital San Vicente Fundación1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies18
Heart Failure6
Cardiovascular Diseases3
Heart Diseases3
Renal Insufficiency3
Cardiomyopathy, Dilated2
Coronary Artery Disease2
Friedreich Ataxia2
Acute Kidney Injury1
Alzheimer Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.